Benjamin Oakes is the founder of Scribe Therapeutics. Scribe Therapeutics has raised $120M in total funding. Latest round: Series A.
Benjamin Oakes is the Co-founder, CEO, and President of Scribe Therapeutics, a gene-editing company he co-founded in October 2018. He previously worked in Jennifer Doudna's lab at UC Berkeley and participated in the Entrepreneurial in Genomics program.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide